Follow the CTT PHARMACEUTICAL HOLDINGS, INC. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €3.5m. The latest transaction was reported on 20 August 2026 (Acquisition). Among the most active insiders: CTT PHARMACEUTICAL HOLDINGS, INC.. Every trade is accessible without an account.
55
Insider Decl.
n/a
Thresholds
€47,586
52 ops.
Buy Volume
n/a
n/a
Sell Volume
32Σ signal
Buys €47,586n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,100 shares@ US$0.0550.1% of flowCTTHSEC:0001035422-24-000024:0
Canonical exit: 10 Dec 2024 (T+90)
25 of 55 declarations
About CTT PHARMACEUTICAL HOLDINGS, INC.
CTT PHARMACEUTICAL HOLDINGS, INC. is a company focused on the development and commercialization of pharmaceutical products. It is listed on NASDAQ under the ticker CTT.